Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 2, 2007, Pages 207-213

  Cuculich, Phillip S ^a   Sánchez, José Mauricio ^a   Kerzner, Roger ^a   Greenberg, Scott L ^a   Sengupta, Jay ^a   Chen, Jane ^a   Faddis, Mitchell N ^a   Gleva, Marye J ^a   Smith, Timothy W ^a   Lindsay, Bruce D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Defibrillator; ICD; Sudden death; Survival

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEFIBRILLATOR; DIALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SUDDEN DEATH; SURVIVAL;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MISSOURI; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33847403128     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00651.x     Document Type: Article

References (36)

1. Coresh J, Astor BC, Astor BC, Greene T, Eknoyan, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult U.S. population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12.
2. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusaf S, Granger CB, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113:671-678.
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
4. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108:2154-2169.
5. Ljungman S, Kjekshus J, Swedberg K. Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). Am J Cardiol 1992; 70:479-487.
6. Dries DL, Exner DV, Domanski MJ,Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 2000; 35:681-689.
7. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hamptom JR, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102;203-210.
8. Ruilope LM,VanVeldhuisen DJ, Ritz E, Luscher TF. Renal function: The Cinderella of cardiovascular risk profile. J Am Coll Cardiol 2001; 38:1782-1787.
9. Al Ahmad A, Rand WM, Manjunath G. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38:955-962.
10. Mahon NG, Blackstone EH, Francis GS, Starling RC III, Young JB, Lauer MS. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 2002; 40:1106-1113.
11. Hillege HL, van Gilst WH, Van Veldhuisen DJ, Navis G, Grobbee DE, de Graeff PA, de Zeeuw D. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: The CATS randomized trial. Eur Heart J 2003: 24:412-420.
12. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:1285-1295.
13. Jones RC, Francis GS, Lauer MS. Predictors of mortality in patients with heart failure and preserved systolic dysfunction in the Digitalis Investigation Group trial. J Am Coll Cardiol 2004; 44:1025-1029.
14. Smilde TD, Hillege HL, Voors AA, Dunselman PH, Van Veldhuisen DJ. Prognostic importance of of renal function in patients with early heart failure and mild left ventricular dysfunction. Am J Cardiol 2004; 94:240-243.
15. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109:1004-1009.
16. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164:659-663.
17. U.S. Renal Data System: USRDS 2005 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005.
18. U.S. Renal Data System: USRDS 2003 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
19. Moss AJ, Zareba W, Hall WJ, Klein H, Wilbur DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
20. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-237.
21. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
22. Wase A, Basit A, Nazir R, Jamal A, Shah S, Khan T, Mohiuddin I, et al. Impact of chronic kidney disease among implantable cardioverter-defibrillators recipients. J Intervent Card Electrophys 2004; 11:199-204.
23. Hreybe H, Ezzeddine R, Bedi M, Barrington W, Bazaz R, Ganz LI, Jain S, et al. Renal insufficiency predicts time to first appropriate defibrillator shock. Am Heart J 2006; 151:852-856.
24. Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ. Clinical characteristics and outcome of patients with high defibrillation thresholds - A multicenter study. Circulation 1992; 86:1206-1216.
25. Converse RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. New Engl J Med 1992; 327:1912-1918.
26. McCullough PA. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol 2003; 41:725-728.
27. Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ, Ball S, et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004; 43:244-253.
28. Voigt A, Ezzeddine R, Barrington W, Obiaha-NgwuO, Ganz LI, London B, Sata S. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol 2004; 44:855-858.
29. Herzog CA, Shuling L,Weinhandl ED, Strief JW, CollinsAJ, Gilbertson DT. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 2005; 68:818-825.
30. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003; 42:201-208.
31. Wright RS, Reeder GS, Herzog CA, Albright RC,Williams BA, Dvorak DL, Miller WL, et al. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 2002; 137:563-570.
32. Shilpak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002; 137:555-562.
33. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Gara M, McCullough PA. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001; 37:1191-1200.
34. McCullough PA, Sandberg KR, Borzak S, HudsonMP, Garg M, Manley HJ. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 2002; 144:226-232.
35. Pritt BS, Hardin NJ, Rishmond JA, Shapiro SL. Death certificate errors at an academic institution. Archive Pathol Lab Med 2005; 129:1476-1479.
36. Messite J, Stellman SD. Accuracy of death certificate completion. JAMA 1996; 275:794-796.